Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-23-001075
Filing Date
2023-02-13
Accepted
2023-02-13 12:37:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 CHI ADVISORS LLC plrxa2_21323.htm SC 13G/A 26416
  Complete submission text file 0001085146-23-001075.txt   27913
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Subject) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91525 | Film No.: 23616233
SIC: 2834 Pharmaceutical Preparations

Mailing Address 599 LEXINGTON AVENUE 20TH FLOOR NEW YORK NY 10022
Business Address 599 LEXINGTON AVENUE 20TH FLOOR NEW YORK NY 10022 2122014829
CHI Advisors LLC (Filed by) CIK: 0001791468 (see all company filings)

EIN.: 141874283 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC 13G/A